| Gene: | CD33 |
| GeneID: | ENSG00000105383 |
| Chrom: | 19 |
| Start position: | 51225064 |
| End position: | 51243860 |
| Pathway: | Hematopoietic cell lineage |
| Class: | Organismal Systems; Immune system |
| FST gene level: | 0.110292 |
| Number of nsSNPs: | 6 |
| nsSNPs in gene: | rs11882250 rs12459419 rs2455069 rs35112940 rs58981829 rs61736475 |
| Gene Structure: |  |
|
Overall distribution |
Tissue specific distribution |
||||
|
|
|
||||
|
Overall distribution |
Tissue specific distribution |
||||||
|
|
||||||
|
Overall distribution |
Tissue specific distribution |
||||
|
|
||||
| Functional class: | Not specified |
| JensenLab PubMed score: | 774.44 (Percentile rank: 93.93%) |
| PubTator score: | 888.12 (Percentile rank: 96.00%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
Copyright © 2024 University of Pennsylvania. All Rights Reserved.
Data portal developer
Yuxin Wang MD, PhD
University of Pennsylvania School of Medicine
Peking Union Medical College Hospital